Intracytoplasmic sperm injection as a complement to gonadotrophin treatment in infertile men with hypogonadotrophic hypogonadism. 2005

Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
Reproductive Unit, Andrology Centre, Department of Obstetrics and Gynecology, University Medical Centre, Ljubljana, Slovenia. branko.zorn@kclj.si

In this study we sought to determine whether intracytoplasmic sperm injection (ICSI) could improve the efficacy of treatment with gonadotrophins in gonadotrophin-deficient men in terms of pregnancy. A series of six adult men (aged 26-47 years) with hypogonadotrophic hypogonadism (HH) is reported: four men with prepubertal isolated idiopathic HH (IIHH) and two adult-onset HH, as part of hypopituitarism secondary to surgical treatment of a pituitary tumour. All were azoospermic. To restore spermatogenesis, all received hormonal treatment with intramuscular human menopausal gonadotrophins (HMG) and human chorionic gonadotrophin (HCG) for 2 to 23 months. High basal serum inhibin B was predictive of rapid and complete recovery of spermatogenesis. In the two adult-onset HH, a natural pregnancy was achieved within 3 months. The four men with IIHH underwent ICSI because of poor sperm quality. ICSI using fresh or frozen-thawed ejaculated spermatozoa was performed after 6-23 months of gonadotrophin treatment. ICSI provided good clinical results in terms of fertilization and embryo quality, and resulted in three pregnancies that ended in three term deliveries. In men with oligozoospermia related to prepubertal IIHH, ICSI shortens the hormonal treatment and enhances the chances of pregnancy.

UI MeSH Term Description Entries
D007006 Hypogonadism Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism). Hypergonadotropic Hypogonadism,Hypogonadism, Isolated Hypogonadotropic,Hypogonadotropic Hypogonadism,Hypogonadism, Hypergonadotropic,Hypogonadism, Hypogonadotropic
D008297 Male Males
D006063 Chorionic Gonadotropin A gonadotropic glycoprotein hormone produced primarily by the PLACENTA. Similar to the pituitary LUTEINIZING HORMONE in structure and function, chorionic gonadotropin is involved in maintaining the CORPUS LUTEUM during pregnancy. CG consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is virtually identical to the alpha subunits of the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity (CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN). Chorionic Gonadotropin, Human,HCG (Human Chorionic Gonadotropin),Biogonadil,Choriogonadotropin,Choriogonin,Chorulon,Gonabion,Human Chorionic Gonadotropin,Pregnyl,Gonadotropin, Chorionic,Gonadotropin, Human Chorionic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013091 Spermatogenesis The process of germ cell development in the male from the primordial germ cells, through SPERMATOGONIA; SPERMATOCYTES; SPERMATIDS; to the mature haploid SPERMATOZOA. Spermatocytogenesis,Spermiogenesis
D013737 Testis The male gonad containing two functional parts: the SEMINIFEROUS TUBULES for the production and transport of male germ cells (SPERMATOGENESIS) and the interstitial compartment containing LEYDIG CELLS that produce ANDROGENS. Testicles,Testes,Testicle
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D020554 Sperm Injections, Intracytoplasmic An assisted fertilization technique consisting of the microinjection of a single viable sperm into an extracted ovum. It is used principally to overcome low sperm count, low sperm motility, inability of sperm to penetrate the egg, or other conditions related to male infertility (INFERTILITY, MALE). ICSI,Injections, Sperm, Intracytoplasmic,Intracytoplasmic Sperm Injections,Injection, Intracytoplasmic Sperm,Injections, Intracytoplasmic Sperm,Intracytoplasmic Sperm Injection,Sperm Injection, Intracytoplasmic

Related Publications

Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
December 2009, Human fertility (Cambridge, England),
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
June 1997, Human reproduction (Oxford, England),
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
August 2007, Reproductive biomedicine online,
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
March 2017, Clinical endocrinology,
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
July 2004, Human reproduction (Oxford, England),
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
January 2020, Asian journal of andrology,
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
January 2016, Endocrinology, diabetes & metabolism case reports,
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
July 1997, Texas medicine,
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
January 1990, Reproduction, fertility, and development,
Branko Zorn, and Marija Pfeifer, and Irma Virant-Klun, and Helena Meden-Vrtovec
September 1977, Helvetica paediatrica acta,
Copied contents to your clipboard!